Literature DB >> 11301071

(+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice.

R R Matsumoto1, A L Mack.   

Abstract

Cocaine interacts with sigma receptors at physiologically relevant concentrations. While earlier studies demonstrate that antagonism of sigma(1) receptors attenuates the behavioral actions of cocaine, the contribution of sigma(2) receptors is unclear. Therefore, in the present study, 3 alpha-tropanyl-2-(4-chlorophenoxy)butyrate ((+/-)-SM 21), a compound with high and preferential affinity for sigma(2) receptors, was tested for its ability to attenuate cocaine-induced behaviors. Pre-treatment of Swiss Webster mice with (+/-)-SM 21 significantly attenuated cocaine-induced convulsions and locomotor activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301071     DOI: 10.1016/s0014-2999(01)00891-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

2.  The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands.

Authors:  Lidiya Stavitskaya; Michael J Seminerio; Marilyn M Matthews-Tsourounis; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2010-03-01       Impact factor: 2.823

3.  Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

Authors:  J Kitanaka; N Kitanaka; T Tatsuta; F S Hall; G R Uhl; K Tanaka; N Nishiyama; Y Morita; M Takemura
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

4.  Activation of σ-receptors induces binge-like drinking in Sardinian alcohol-preferring rats.

Authors:  Valentina Sabino; Pietro Cottone; Angelo Blasio; Malliga R Iyer; Luca Steardo; Kenner C Rice; Bruno Conti; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

5.  Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.

Authors:  Rae R Matsumoto; Buddy Pouw; Aisha L Mack; Antawan Daniels; Andrew Coop
Journal:  Pharmacol Biochem Behav       Date:  2006-12-22       Impact factor: 3.533

6.  Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.

Authors:  Linda Garcés-Ramírez; Jennifer L Green; Takato Hiranita; Theresa A Kopajtic; Maddalena Mereu; Alexandra M Thomas; Christophe Mesangeau; Sanju Narayanan; Christopher R McCurdy; Jonathan L Katz; Gianluigi Tanda
Journal:  Biol Psychiatry       Date:  2010-10-15       Impact factor: 13.382

7.  Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Luca Steardo; George F Koob; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

8.  Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-11-05       Impact factor: 4.030

9.  Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.

Authors:  Rae R Matsumoto; Jamaluddin Shaikh; Lisa L Wilson; Shreedeepalakshmi Vedam; Andrew Coop
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-27       Impact factor: 4.600

10.  The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Malliga R Iyer; Luca Steardo; Luca Steardo; Kenner C Rice; Bruno Conti; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.